Potassium tert-butoxide (0.010 g, 0.090 mmol) was added into a solution of 1·2OTf (0.095 g, 0.083 mmol) in 10 mL of EtOH. After 15 min at room temperature finely grounded solid CoCl 2 ·6H 2 O (0.022 g, 0.094 mmol) was added. The resulting blue solution kept for 30 minutes at room temperature and then reduced to 5 mL under reduced pressure. The resulting blue solid was recrystallized in EtOH, providing green microcrystals that were filtered and air dried. 
X-ray analysis of 2·OTf·0.25H 2 O.
A single crystal with suitable dimensions (0.041 x 0.02 x 0.015) was mounted on a glass fibber with cyanoacrylate at room temperature. Data collection was performed on a Bruker APEX-II CCD diffractometer in the range 0.963 ≤ 2θ ≤ 26.804. Data were collected at 100(2) o K using graphite-monochromatized Mo-Kα (λ = 0.71073) in the range −7 ≤ h ≤ 14, −25 ≤ k ≤ 26, −28 ≤ l ≤ 28. The structure was determined by direct method and refined by least-squares procedures on F 2 (SHELX-XTL) by Olex2 package. 2, 3 The function minimized during the refinement was w = 1/[σ 2 (F 0 2 )+(0.0440P) 2 + 10.2700P]. The final geometrical calculations, the graphical manipulations and the analysis of H-bond network and other crystallographic calculations were carried out with Olex2 package. 3 In the final least squares cycles all non-H atoms were allowed to vibrate anisotropically. The hydrogen atoms were located at the calculated positions and assigned a fixed displacement. The chloride ligand (Cl3) was found to be disordered (Uani = 0.27) and refined anisotropically. The 0.25 H 2 O molecules are disordered between two positions with occupancy factors 0.405 (O0AA) and 0.095 (O1AA). Crystal data and data collection details are given in Table S1 . CCDC 1545888 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via the World Wide Web (or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB21EZ, UK; fax: (+44)1223-336-033 or emailing deposit@ccdc.cam.ac.uk) Figure S3 . 13 
Stability of 2·OTf·0.25H 2 O in DMSO-d 6 .
Crystals of 2·OTf·0.25H 2 O (5.4 mg; 0.0047 mmol) were added into a 5 mm NMR containing 0.5 mL of DMSO-d 6 under N 2 . The recorded 31 P{ 1 H} NMR after 10 minutes showed that the {CoCl 2 } unit was realized from complex 2·OTf·0. Two 5 mm NMR tubes were prepared containing 2·OTf·0.25H 2 O (5.4 mg; 0.0047 mmol). Into one of them was introduced 0.5 mL of DMSO-d 6 . In other, 0,5 mL of DMSO-d6 was added and 0.6 mL of the used cell culture medium. The resulting dissolutions were kept at room temperature and recorded by 31 P{ 1 H} NMR along the time. In both tubes the NMR the obtained results were similar. The complex initially releases slowly the {CoCl 2 } unit and further also slowly the release of one PPh 3 starts. Similar results were obtained when air was bubbled into the solutions. A faster but similar reaction was observed when both solutions were kept at 40 C. 
Reactivity of NaCl in a solution of 2·OTf·0.25H2O first dissolved in DMSO and immediately with D 2 O.
NaCl (12.8 mg, 0.219 mmol) was added into a solution obtained by dissolution of 2·OTf·0.25H 2 O (50 mg, 0.043 mmol) first in 10 mL of DMSO and immediately in 50 mL of water. The resulting solution was stirred at room temperature over nigh and the solvent evaporated under vacuum. The obtained powder showed the same 31 P{ 1 H} NMR that complex [RuCpCl(PPh 3 )(HdmoPTA-P)] + previously published by us. 4 We must note that, single crystals good enough to be used for X-ray structure determination were obtained from ethanol by slow evaporation at room temperature. The resolution of the crystal structure showed that the obtained complex is [RuCpCl(PPh 3 )(HdmoPTA-P)] + as suggested by 31 P{ 1 H} NMR.
Stability of 2·OTf·0.25H 2 O in CDCl 3 .
Into a 5 mm NMR tube was dissolved 2·OTf·0.25H 2 O (8.3 mg, 0.007 mmol) in 0.5 mL of CDCl 3 . The 31 P{ 1 H} NMR showed that the complex slowly releases a PPh 3 initially and further the elimination of the {CoCl 2 } unit was started. Reaction was accelerated at 40 C. Bubbling air into the solution does not produce any modify of the reaction tendency. The 31 P{ 1 H} NMR shows that after 3 days 2·OTf·0. 
Growth inhibition assays
The human solid tumor cell lines A549, HBL-100, HeLa, SW1573, T-47D and WiDr were used in this study. These cell lines were a kind gift from Prof. G. J. Peters (VU Medical Center, Amsterdam, Netherlands). Cells were maintained in 25 cm 2 culture flasks in RPMI 1640 supplemented with 5% heat inactivated fetal calf serum and 2 mM L-glutamine in a 37 °C, 5% CO 2 , 95% humidified air incubator. Exponentially growing cells were trypsinized and resuspended in antibiotic containing medium (100 units of penicillin G and 0.1 mg of streptomycin per mL). Single cell suspensions displaying >97% viability by trypan blue dye exclusion were subsequently counted. After counting, dilutions were made to give the appropriate cell densities for inoculation onto 96-well microtiter plates. Cells were inoculated in a volume of 100 μL per well at densities of 2 500 (A549, HBL-100 and HeLa) and 5 000 (SW1573, T-47D and WiDr) cells per well, based on their doubling times. Compounds were initially dissolved in DMSO at 400 times the desired final maximum test concentration. Control cells were exposed to an equivalent concentration of DMSO (0.25% v/v, negative control). Each agent was tested in triplicate at different dilutions in the range of 1-100 μM.
The drug treatment was started on day 1 after plating. Drug incubation times were 48 h, after which time cells were precipitated with 25 μL ice-cold TCA (50% w/v) and fixed for 60 min at 4 °C. Then the SRB assay was performed. The optical density (OD) of each well was measured at 530 nm, using BioTek's PowerWave XS Absorbance Microplate Reader. Values were corrected for background OD from wells only containing medium. 9 Figure S8 . Representative histograms of cells treated with complex 1·2Otf (0.5 µM) or complex 2·OTf·0.25H 2 O (0.1 µM) for 24 h. Cisplatin was used as reference drug.
